gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · CBUSMaterialsAgricultural Chemicals

Cibus, Inc. Class A Common Stock (CBUS)

$1.24+8.77%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$1.24▼ 9.49% in range
Nov 4, 2025Low $1.14 · High $4.05Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Cibus closed at $1.24 on Nov 4, up 8.77%, 69.4% below its 52-week closing high. Volume of 105.5K shares was 1.54× its 20-day average (above normal).

Split-adjusted performance: -21.0% over one month, -22.0% over six months, -14.2% over one year.

In the quarter ended Jun 30, 2026, revenue was $994K, up 6.5% from a year earlier, with a net margin of -2227.9%.

Short interest was 3.1M shares at the Oct 15 settlement, down 5.7% from the prior report (6.2% of float, 25.4 days to cover).

Market cap$94.8M76.4M shares
Revenue · quarter$994.0K+6.5% YoY
Diluted EPS$-0.29—
P/E · TTM—P/S 21.8×
Net margin-2,227.9%Gross 100.0%
Dividend yieldNone
52-week range1.14 – 4.05−69.4% from high
Volume105.5K1.54× 20-day avg
Volatility · 60d57.8%Annualised
Short % of float6.2%25.4 days to cover
Net cash$19.6MCash $20.4M
Next earnings—Not scheduled
Split-adjusted performance
1W −12.1%1M −21.0%3M −33.7%6M −22.0%YTD −28.7%1Y −14.2%3Y −88.3%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Agricultural Chemicals

Percentile among 7 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −14.1%, revenue growth +1.1%, net margin −8.5%, P/E 11.1×.

Short interest

Details →
Shares short3.1M−5.7% vs prior
Days to cover25.4Settled Oct 15
% of float6.2%
Short vol. 10d50.2%of daily volume

Closest peers by size in Agricultural Chemicals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
CBUSCibus$1.24+8.77%−22.0%+6.5%−2227.9%—$94.8M
AVDAmerican Vanguard$0.9759−7.06%−66.5%−9.7%−8.5%—$28.8MCompare
UANCVR Partners, LP$112.02−5.56%−14.1%−10.6%−7.3%11.1$1.18BCompare
SNESSenesTech$1.21−2.42%−17.7%+23.2%−237.9%—$6.6MCompare
SMGThe Scotts Miracle-Gro$67.19+8.72%+6.9%+1.1%9.6%52.9$3.91BCompare
MOSThe Mosaic$21.62+17.37%−8.2%−6.0%−9.7%—$6.87BCompare
CFCF Industries Holding$111.68−4.39%−6.7%+17.6%32.7%8.1$16.90BCompare

News about Cibus

All news →
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value CreationGlobeNewswire Inc. · Jun 8, 2026▲ PositiveCibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and ProductionGlobeNewswire Inc. · May 4, 2026▲ Positive

Quick answers

What does Cibus do?
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies.
What is CBUS's market cap?
$94.77M, based on the Nov 4 close of $1.24.
Does Cibus pay a dividend?
No regular cash dividend has been paid in the last year.
How much of CBUS is sold short?
3.1M shares, 6.2% of float, as of Oct 15, 2026.
What sector is CBUS in?
Materials, in the Agricultural Chemicals industry.

About Cibus

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

HQ: San Diego, CA118 employeesListed Jul 20, 2017cibus.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology